André E. Merbach

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTInorganic and Bioinorganic Solvent Exchange MechanismsLothar Helm and André E. MerbachView Author Information Laboratoire de chimie inorganique et bioinorganique, Ecole polytechnique fédérale de Lausanne, EPFL-BCH, CH-1015 Lausanne, Switzerland Cite this: Chem. Rev. 2005, 105, 6, 1923–1960Publication Date (Web):April 2, 2005Publication History Received24 September 2004Published online2 April 2005Published inissue 1 June 2005https://pubs.acs.org/doi/10.1021/cr030726ohttps://doi.org/10.1021/cr030726oresearch-articleACS PublicationsCopyright © 2005 American Chemical SocietyRequest reuse permissionsArticle Views7827Altmetric-Citations666LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Ions,Kinetic parameters,Metals,Molecules,Solvents Get e-Alerts

We present the results of new and previously published 17O NMR, EPR, and NMRD studies of aqueous solutions of the Gd3+ octaaqua ion and the commercial MRI contrast agents [Gd(DTPA)(H2O)]2- (MAGNEVIST, Schering AG, DTPA = 1,1,4,7,7-pentakis(carboxymethyl)-1,4,7-triazaheptane), [Gd(DTPA-BMA)(H2O)] (OMNISCAN, Sanofi Nycomed, DTPA-BMA = 1,7-bis[(N-methylcarbamoyl)methyl]-1,4,7-tris(carboxymethyl)-1,4,7-triazaheptane), and [Gd(DOTA)(H2O)]- (DOTAREM, Guerbet, DOTA = 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane). High-field EPR measurements at different concentrations give evidence of an intermolecular dipole−dipole electronic relaxation mechanism that has not previously been described for Gd3+ complexes. For the first time, the experimental data from the three techniques for each complex have been treated using a self-consistent theoretical model in a simultaneous multiple parameter least-squares fitting procedure. The lower quality of the fits compared to separate fits of the data for each of the three techniques shows that the increase in the number of adjustable parameters is outweighed by the increased constraint on the fits. The parameters governing the relaxivity of the complexes are thus determined with greater confidence than previously possible. The same approach was used to study two dimeric Gd3+ complexes [pip{Gd(DO3A)(H2O)}2] and [bisoxa{Gd(DO3A)(H2O)}2] (pip(DO3A)2 = bis(1,4-(1-(carboxymethyl)-1,4,7,10-tetraaza-4,7,10-tris(carboxymethyl)-1-cyclododecyl-1,4-diazacyclohexane, bisoxa(DO3A)2 = bis(1,4-(1-(carboxymethyl)-1,4,7,10-tetraaza-4,7,10-tris(carboxymethyl)-1-cyclododecyl))-1,10-diaza-3,6-dioxadecane) that are being developed as potential second-generation MRI contrast agents. These dimeric complexes are expected to have higher relaxivities than the monomeric contrast agents, due to their longer rotational correlation times. The results of this study show that further relaxivity gain for these complexes will be hindered by the slow rate of water exchange on the complexes. High-field EPR measurements suggest that there is a previously unrecorded intramolecular dipole−dipole mechanism of electronic relaxation, but that this additional contribution to electronic relaxation is of minor importance compared to the limiting effect of water exchange rates in the determination of proton relaxivity in MRI applications.

A variable-temperature, -pressure, and -ionic strength (1)H NMR study of the DOTA complexes of different trivalent cations (Sc, Y, La, Ce --> Lu) (DOTA = 1,4,7,10-tetraaza-1,4,7,10-tetrakis(carboxymethyl)cyclododecane) yielded data that are in contradiction with the hitherto used model of only two enantiomeric pairs of diastereoisomers that differ in the ligand conformations. A two-isomer equilibrium cannot explain the newly observed apparent reversal of the isomer ratio at the end of the series. As both conformers may lose their inner sphere water molecule, a coordination equilibrium may be superimposed on this conformational equilibrium, as shown by large positive reaction volumes for the isomerization of [Ln(DOTA)(H(2)O)(x)()](-) (Ln = Yb, Lu; x = 1, 0). The isomerization of [Nd(DOTA)(H(2)O)](-) and [Eu(DOTA)(H(2)O)](-) is purely conformational, as shown by near-zero reaction volumes. The measured isomerization enthalpies and entropies agree with this model. The shift of the isomerization equilibria by a variety of non-coordinative salts depends on the ligand conformation rather than the presence or absence of the inner sphere water molecule. This results from weak ion binding and water solvent stabilization of one ligand conformation, rather than the decrease of the activity of the bulk water in the solution, as shown by UV-vis measurements of the coordination number sensitive transition (5)F(0) --> (7)D(0) of Eu(III) as a function of ionic strength. Fluoride ions replace a water molecule in the inner coordination sphere, preferentially for one of the conformational isomers, as proven by (19)F-NMR shifts and the appearance of a third set of resonances corresponding to [Eu(DOTA)F](2)(-) in the (1)H-NMR spectrum of [Eu(DOTA)(H(2)O)](-).

We report the nanoscale loading and confinement of aquated Gd3+n-ion clusters within ultra-short single-walled carbon nanotubes (US-tubes); these Gd3+n@US-tube species are linear superparamagnetic molecular magnets with Magnetic Resonance Imaging (MRI) efficacies 40 to 90 times larger than any Gd3+-based contrast agent (CA) in current clinical use.

The water-soluble endohedral gadofullerene derivatives, Gd@C(60)(OH)(x) and Gd@C(60)[C(COOH)(2)](10), have been characterized with regard to their MRI contrast agent properties. Water-proton relaxivities have been measured in aqueous solution at variable temperature (278-335 K), and for the first time for gadofullerenes, relaxivities as a function of magnetic field (5 x 10(-4) to 9.4 T; NMRD profiles) are also reported. Both compounds show relaxivity maxima at high magnetic fields (30-60 MHz) with a maximum relaxivity of 10.4 mM(-1) s(-1) for Gd@C(60)[C(COOH)(2)](10) and 38.5 mM(-1) s(-1) for Gd@C(60)(OH)(x) at 299 K. Variable-temperature, transverse and longitudinal (17)O relaxation rates, and chemical shifts have been measured at three magnetic fields (B = 1.41, 4.7, and 9.4 T), and the results point exclusively to an outer sphere relaxation mechanism. The NMRD profiles have been analyzed in terms of slow rotational motion with a long rotational correlation time calculated to be tau(R)(298) = 2.6 ns. The proton exchange rate obtained for Gd@C(60)[C(COOH)(2)](10) is k(ex)(298) = 1.4 x 10(7) s(-1) which is consistent with the exchange rate previously determined for malonic acid. The proton relaxivities for both gadofullerene derivatives increase strongly with decreasing pH (pH: 3-12). This behavior results from a pH-dependent aggregation of Gd@C(60)(OH)(x) and Gd@C(60)[C(COOH)(2)](10), which has been characterized by dynamic light scattering measurements. The pH dependency of the proton relaxivities makes these gadofullerene derivatives prime candidates for pH-responsive MRI contrast agent applications.